Drug recall: Cipla recalls these 6 batches of Albuterol Sulfate Inhalation Aerosol due to this reason

Cipla is notifying its distributors and customers by letter and is arranging for return and replacement of all recalled products.

512
Drug product Recall
Drug Recall

Last Updated on January 3, 2024 by The Health Master

Cipla announced that its wholly-owned subsidiary, Cipla USA Inc, is voluntarily recalling six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) manufactured in November 2021 to the consumer level.

Detail of batches:

Sr. NoProduct NameBatch NoExpiry Date
1Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)IB20045Nov.2023 
2Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)IB20055Nov.2023 
3Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)IB20056Nov.2023 
4Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)IB20057Nov.2023 
5Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)IB20059Nov.2023 
6Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)IB20072Nov.2023 

In a statement, the company said:

“There is a reasonable probability that failure to deliver the recommended dose to treat the respiratory symptoms of acute asthma exacerbations such as wheezing coughing, shortness of breath and bronchospasms, due to device defect, may be life-threatening.”

“There were no adverse events reported for Albuterol Sulfate Inhalation Aerosol 90 mcg related to this recall.”

“The company is initiating a recall in the US due to a market complaint for one single inhaler (Batch Number – IB20056), where leakage was observed through the inhaler valve.”

“Out of an abundance of precaution, of the above mentioned six batches manufactured using the same lot of valves are being recalled.”

The product is used for the treatment and prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise induced bronchospasm.

The product is packaged in 17ml plain aluminium aerosol canister integrated with dose counter coupled with plastic actuator and dust cap, each pack claims 200 metered inhalations and associated codes NDC-69097-142- 60.

These six batches were distributed Nationwide to wholesalers and retailers.

Cipla is notifying its distributors and customers by letter and is arranging for return and replacement of all recalled products.

Consumers / distributors / retailers that have product from these six batches which are being recalled should stop using/return to place of purchase / discard.

This recall is being conducted with the knowledge of the US Food and Drug Administration (USFDA)

Understanding GMP, cGMP, and WHO-GMP

Drug Alert: NSQ Drugs Lists

Medical Device Alert: Lists

Safety alerts issued by IPC

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news